各种动员剂方案在恶性淋巴瘤自身外周血造血干细胞移植中的应用及其临床效果观察  被引量:1

USING THREE KINDS OF MOBILIZED AGENT SCHENE IN MALIGNANT LYMPHOMA COMBINED AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION AND CLINICAL EFFECTIVE OBSERVATION

在线阅读下载全文

作  者:俞受程[1] 张伟京[1] 邓春江[1] 阎安文 马恩普 刘淑珍 苏航[1] 鲍云华[1] 

机构地区:[1]解放军第307医院肿瘤科

出  处:《上海医学》1996年第10期590-594,共5页Shanghai Medical Journal

摘  要:对3组共20例恶性淋巴瘤病人进行自身外周血干细胞回输,采用三种不同的动员剂和治疗方案:1.皮质激素动员;口服强的松或静注地塞米松可使收集浓聚的白细胞明显增多,为给药前自身血的4.bl倍和7.24倍。2.硫酸葡聚糖(DS)动员:10%葡萄糖液9~10ml+N,S.100ml静滴,在外周血干细胞高峰期进行分离,其WBC,MNC和CFU-GM分别为使用前的2.04倍、4.14倍和2.04倍。3.G-CSF或CTX+G-CSF动员:平均分离2.6次总数可获得WBC15.47×l0 ̄9、MNC13.89×l0 ̄9、CFU-GM25.4×l0 ̄5、13.24×l0 ̄7。临床应用:1.激素动员组化疗采用CTX+VCR,分别输入2,11×10 ̄9和2.40×l0 ̄9,其中CFU-C产率为0.72×l0 ̄5和0.33×l0 ̄5,可以加速造血恢复。2.DS动员组化疗采用CHVP方案,输入自身干细胞MNC5.5×l0 ̄9、CFU-GM1.54×l0 ̄5。输后14天白细胞(WBC)恢复至4×l0 ̄9/L以上,PT在输后16天恢复至照前水平。3.G-CSF或CTX+G-CSF动员组化疗采用CHVP方案或超大剂量化疗(BCNU+VP-?0 cases malignant lymphoma were divided into three groups which patients reinfusedautologous peripheral stem cells and adopted three kinds of mobilized agent and chemo-thera-peutic scheme,1.Hormone Group:Using pred.or dexamethasone,WBC was increased significantly. It was 4. 6l and 7.24 fold compared with pre-mobilization,After chemotherapy(CTX+VCR),MNC(2.11×109and2.40×109)andCFU-GM(0.7×105 nd 0.33×105)wasreinfused.It hastened hemopoietic reconstitution,2.Dextron sulfate(DS)Group:10%DS9~10ml+N.S. 100ml I.V.The WBC,MNC and CFU-GM was 2.04,4.14 and 2.04 fold respectively compared with pre-mobilization. After chemotherapy(CHVP),the total MNC(5.5 × 109)and CFU-GM(1.54 × l05) was refused.WBC recovered more than 4× l09/L in14 days,while Pt was in l6 days at normal level.3.G-CSF or CTX+G-CSF Group:Afterhigh dose chemotherapy or super high dose chemotherapy(CHVP or BCNU + Vp-l6 +CTX),thetotal WBC(15.47×109),MNC(13.89×109),CFU-GM(25.4×105),cells(13.24× 107)was reinfused.WBC recovered more than 2.2×109/L in l6 days,wmkPt was50×109/L in l9 days. It was an ideal stem cell mobilized agent and satisfactory effect for tu-mour remission.

关 键 词:淋巴肉瘤 造血干细胞移植 自体移植 

分 类 号:R733.405[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象